Lavaca Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-9,000
Closed -$326K – 172
2021
Q1
$326K Buy
+9,000
New +$320K 0.03% 107

Other funds holding PFE

Lavaca Capital's PFE Position: Q3 2026 in Review

Lavaca Capital increased its Pfizer (PFE) stake by 2.9% in Q3 2026, buying an estimated $8.3K and bringing the position to 11,185 shares worth $319K. The position accounts for 0.03% of the portfolio, ranked #107.

Lavaca Capital first reported a position in PFE in Q4 2018 and has held it in 32 quarters since. The position peaked at $2.44M in Q1 2021. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Lavaca Capital held 11,185 shares of Pfizer worth $319K as of Q3 2026.
  • Lavaca Capital bought 312 Pfizer shares in Q3 2026, an estimated $8.3K.
  • Pfizer made up 0.03% of Lavaca Capital's portfolio in Q3 2026, its #107 holding.
  • Lavaca Capital first reported a position in Pfizer in Q4 2018 and has held it in 32 quarters since.
  • Lavaca Capital's Pfizer position peaked at $2.44M in Q1 2021.
  • 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Lavaca Capital's 13F filing for Q3 2026, filed 16 Nov 2026.